naltrexone has been researched along with Emesis in 15 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (33.33) | 18.2507 |
2000's | 5 (33.33) | 29.6817 |
2010's | 4 (26.67) | 24.3611 |
2020's | 1 (6.67) | 2.80 |
Authors | Studies |
---|---|
Ishikawa, H; Sato, J; Shino, M; Suzuki, T; Tanaka, R | 1 |
Abdel-Rahman, S; Adelman, W; Dietz, A; Stancil, SL | 1 |
Stettler, A; Zulian, GB | 1 |
Schairer, J; Thapa, SD | 1 |
Bertschy, G; Besson, J; Bochud Tornay, C; Daeppen, JB; Favrat, B; Monnat, M; Schnyder, C | 1 |
Chiao, F; Erice, S; Leverone, T; Ma, H; Pearce, S; Quon, R; Tang, J; Wender, RH; White, PF | 1 |
Bass, AS; Foss, JF; Goldberg, LI | 1 |
Camu, F; Franck, P; Moerman, I | 1 |
Foss, JF; Goldberg, LI; Roizen, MF; Yuan, CS | 1 |
Chehade, J; Duffy, L; Gajraj, N; Johnson, ER; Joshi, GP; Wesevich, J | 1 |
Cheng, CH; Naylor, RJ; Ngan, MP; Rudd, JA; Wai, MK | 1 |
Chanmugam, AS; Ezenkwele, U; Hengeller, M | 1 |
Bristow, K; Clark, N; Meek, R | 1 |
Hamilton, RJ; Hoffman, RS; Howland, MA; Hung, OL; Lewin, NL; Nelson, LS; Olmedo, RE; Perrone, J; Shah, S | 1 |
2 trial(s) available for naltrexone and Emesis
Article | Year |
---|---|
Evaluation of methylnaltrexone for the reduction of postoperative vomiting and nausea incidences.
Topics: Adult; Antiemetics; Double-Blind Method; Female; Humans; Middle Aged; Naltrexone; Narcotic Antagonists; Nausea; Postoperative Complications; Prospective Studies; Quaternary Ammonium Compounds; Vomiting | 1995 |
Effects of prophylactic nalmefene on the incidence of morphine-related side effects in patients receiving intravenous patient-controlled analgesia.
Topics: Adult; Analgesia, Patient-Controlled; Analgesics, Opioid; Dose-Response Relationship, Drug; Female; Humans; Middle Aged; Morphine; Naltrexone; Narcotic Antagonists; Nausea; Postoperative Complications; Pruritus; Vomiting | 1999 |
13 other study(ies) available for naltrexone and Emesis
Article | Year |
---|---|
A preliminary study of the effect of naldemedine tosylate on opioid-induced nausea and vomiting.
Topics: Aged; Analgesics, Opioid; Antiemetics; Constipation; Female; Humans; Incidence; Male; Middle Aged; Morphine; Naltrexone; Narcotic Antagonists; Nausea; Oxycodone; Receptors, Opioid; Retrospective Studies; Vomiting | 2020 |
Naltrexone Reduces Binge Eating and Purging in Adolescents in an Eating Disorder Program.
Topics: Adolescent; Binge-Eating Disorder; Bulimia Nervosa; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Off-Label Use; Retrospective Studies; Vomiting | 2019 |
Unexpected side effect of methylnaltrexone.
Topics: Aged; Constipation; Female; Humans; Naltrexone; Narcotic Antagonists; Palliative Care; Quaternary Ammonium Compounds; Vomiting | 2013 |
Narcotic-induced pain.
Topics: Abdominal Pain; Adult; Analgesics, Opioid; Anorexia; Chronic Disease; Diabetes Mellitus, Type 1; Drug Administration Schedule; Endoscopy, Gastrointestinal; Gastroparesis; Humans; Hypertension; Kidney Failure, Chronic; Male; Naltrexone; Narcotic Antagonists; Nausea; Neuralgia; Quaternary Ammonium Compounds; Substance Withdrawal Syndrome; Treatment Outcome; Vomiting | 2015 |
Corrections.
Topics: Arthritis; Capsules; Drug Combinations; Etanercept; Humans; Injections; Isoquinolines; Naltrexone; Nausea; Oxycodone; Palonosetron; Quinuclidines; Serotonin 5-HT3 Receptor Antagonists; Tumor Necrosis Factor-alpha; Vomiting | 2016 |
Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results.
Topics: Adult; Buprenorphine; Conscious Sedation; Family Practice; Female; Follow-Up Studies; Heroin Dependence; Humans; Male; Naltrexone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Outcome and Process Assessment, Health Care; Premedication; Recurrence; Substance Withdrawal Syndrome; Time Factors; Vomiting | 2003 |
The effect of clonidine on gastrointestinal side effects associated with ultra-rapid opioid detoxification.
Topics: Adrenergic alpha-Agonists; Adult; Clonidine; Diarrhea; Female; Gastrointestinal Diseases; Humans; Hypnotics and Sedatives; Male; Middle Aged; Naltrexone; Narcotic Antagonists; Narcotics; Nausea; Opioid-Related Disorders; Retrospective Studies; Substance Withdrawal Syndrome; Treatment Outcome; Vomiting | 2003 |
Dose-related antagonism of the emetic effect of morphine by methylnaltrexone in dogs.
Topics: Animals; Dogs; Dose-Response Relationship, Drug; Injections, Intramuscular; Injections, Intravenous; Male; Morphine; Naltrexone; Narcotic Antagonists; Quaternary Ammonium Compounds; Vomiting | 1993 |
Prevention of apomorphine- or cisplatin-induced emesis in the dog by a combination of methylnaltrexone and morphine.
Topics: Administration, Oral; Animals; Antiemetics; Antineoplastic Agents; Apomorphine; Cisplatin; Dogs; Drug Interactions; Drug Therapy, Combination; Emetics; Male; Morphine; Naltrexone; Narcotics; Quaternary Ammonium Compounds; Vomiting | 1998 |
Modulation of emesis by fentanyl and opioid receptor antagonists in Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Female; Fentanyl; Male; Naloxone; Naltrexone; Narcotic Antagonists; Nicotine; Receptors, Opioid; Shrews; Vomiting | 1999 |
Development of rhabdomyolysis after rapid opioid detoxification with subcutaneous naltrexone maintenance therapy.
Topics: Adolescent; Gastrointestinal Hemorrhage; Heroin Dependence; Humans; Inactivation, Metabolic; Male; Mallory-Weiss Syndrome; Naltrexone; Narcotic Antagonists; Rhabdomyolysis; Shock; Time Factors; Vomiting | 2000 |
Acute opioid withdrawal in the emergency department: inadvertent naltrexone abuse?
Topics: Acute Disease; Adult; Colic; Emergency Medical Services; Female; Heroin; Heroin Dependence; Humans; Injections, Intravenous; Naltrexone; Narcotics; Substance Withdrawal Syndrome; Vomiting | 2001 |
Complications of ultrarapid opioid detoxification with subcutaneous naltrexone pellets.
Topics: Administration, Cutaneous; Adult; Delayed-Action Preparations; Drug Implants; Emergency Treatment; Epilepsy, Tonic-Clonic; Fatal Outcome; Female; Humans; Male; Naltrexone; Narcotic Antagonists; Opioid-Related Disorders; Pulmonary Edema; Risk Assessment; Substance Withdrawal Syndrome; Time Factors; Unconsciousness; Vomiting | 2002 |